The EU Response to the Presence of Nitrosamine Impurities in Medicines

The unexpected detection of nitrosamine impurities in human medicines has recently seen global regulators act to understand the risks of these contaminations to patients and to limit their presence. Over 300 nitrosamines are known, many of which are highly potent mutagenic carcinogens. Regulators fi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Robin Ruepp, Roland Frötschl, Robert Bream, Maria Filancia, Thomas Girard, Andrei Spinei, Martina Weise, Rhys Whomsley
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/6cbe2a2b5d95426d9f6833a958105120
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!